These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18353086)
1. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo? Moseley H; Brancaleon L; Lesar AE; Ferguson J; Ibbotson SH Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):72-5. PubMed ID: 18353086 [TBL] [Abstract][Full Text] [Related]
2. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942 [TBL] [Abstract][Full Text] [Related]
3. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
4. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo. Sandberg C; Halldin CB; Ericson MB; Larkö O; Krogstad AL; Wennberg AM Br J Dermatol; 2008 Nov; 159(5):1170-6. PubMed ID: 18717673 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460 [TBL] [Abstract][Full Text] [Related]
7. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years. Baptista J; Martinez C; Leite L; Cochito M J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497 [TBL] [Abstract][Full Text] [Related]
8. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Christensen E; Mørk C; Skogvoll E Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486 [TBL] [Abstract][Full Text] [Related]
9. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial. Mosterd K; Thissen MR; Nelemans P; Kelleners-Smeets NW; Janssen RL; Broekhof KG; Neumann HA; Steijlen PM; Kuijpers DI Br J Dermatol; 2008 Sep; 159(4):864-70. PubMed ID: 18717680 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. de Bruijn HS; Sluiter W; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):238-46. PubMed ID: 16948825 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease. Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Calzavara-Pinton PG; Venturini M; Capezzera R; Sala R; Zane C Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):144-7. PubMed ID: 15144392 [TBL] [Abstract][Full Text] [Related]
13. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy. McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up. Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580 [TBL] [Abstract][Full Text] [Related]
15. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. Kuijpers DI; Thissen MR; Thissen CA; Neumann MH J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869 [TBL] [Abstract][Full Text] [Related]
16. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010 [TBL] [Abstract][Full Text] [Related]